Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IMVT – Immunovant Inc

IMVT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

23.17

Margin Of Safety %

Put/Call OI Ratio

0.32

EPS Next Q Diff

0.04

EPS Last/This Y

0.19

EPS This/Next Y

0.2

Price

34.13

Target Price

44.6

Analyst Recom

1.62

Performance Q

25.55

Upside

-205.4%

Beta

0.74

Ticker: IMVT




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23IMVT28.910.150.2430522
2026-04-24IMVT28.550.150.0030507
2026-04-27IMVT28.620.150.0230556
2026-04-28IMVT26.970.150.5130578
2026-04-29IMVT26.960.190.0635571
2026-04-30IMVT27.140.190.4335784
2026-05-01IMVT27.130.190.1035796
2026-05-04IMVT27.850.190.0036575
2026-05-05IMVT27.830.180.1738242
2026-05-06IMVT28.690.180.1338296
2026-05-07IMVT27.230.180.0038417
2026-05-08IMVT28.970.170.0239518
2026-05-11IMVT29.080.170.2539741
2026-05-12IMVT28.650.170.0039753
2026-05-13IMVT29.240.170.1340346
2026-05-14IMVT28.990.170.5439904
2026-05-15IMVT27.50.170.0739404
2026-05-18IMVT26.530.050.0522489
2026-05-19IMVT26.30.050.0622933
2026-05-20IMVT35.550.050.5523286
2026-05-21IMVT34.160.270.3127935
2026-05-22IMVT34.130.320.2627397
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23IMVT28.893.4-33.3-2.53
2026-04-24IMVT28.593.4-27.2-2.53
2026-04-27IMVT28.633.4-27.9-2.53
2026-04-28IMVT26.973.46.0-2.53
2026-04-29IMVT26.963.46.3-2.53
2026-04-30IMVT27.163.42.3-2.53
2026-05-01IMVT27.113.43.3-2.53
2026-05-04IMVT27.873.4-12.3-2.53
2026-05-05IMVT27.843.4-11.8-2.53
2026-05-06IMVT28.673.4-29.1-2.53
2026-05-07IMVT27.233.40.7-2.53
2026-05-08IMVT28.963.4-34.7-2.53
2026-05-11IMVT29.073.4-36.9-2.53
2026-05-12IMVT28.613.4-27.6-2.53
2026-05-13IMVT29.241.9-40.5-2.53
2026-05-14IMVT28.981.9-35.1-2.53
2026-05-15IMVT27.491.9-4.6-2.53
2026-05-18IMVT26.551.914.7-2.53
2026-05-19IMVT26.291.90.9-2.53
2026-05-20IMVT35.511.9-168.9-2.53
2026-05-21IMVT34.151.9-147.2-2.53
2026-05-22IMVT34.13- - -2.58
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23IMVT16.085.7022.20
2026-04-24IMVT15.895.7022.20
2026-04-27IMVT15.905.9123.49
2026-04-28IMVT15.905.9123.49
2026-04-29IMVT15.905.9123.49
2026-04-30IMVT15.905.9123.49
2026-05-01IMVT15.905.9123.48
2026-05-04IMVT15.905.7523.48
2026-05-05IMVT15.905.7523.48
2026-05-06IMVT15.905.7523.48
2026-05-07IMVT15.905.7523.48
2026-05-08IMVT15.905.7523.48
2026-05-11IMVT15.906.3823.48
2026-05-12IMVT15.906.3822.38
2026-05-13IMVT15.906.3822.38
2026-05-14IMVT15.906.3822.38
2026-05-15IMVT15.906.3822.38
2026-05-18IMVT15.906.3922.38
2026-05-19IMVT15.906.3922.38
2026-05-20IMVT15.906.3922.38
2026-05-21IMVT15.896.3922.38
2026-05-22IMVT15.756.3923.17
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.67

Avg. EPS Est. Current Quarter

-0.62

Avg. EPS Est. Next Quarter

-0.63

Insider Transactions

15.75

Institutional Transactions

6.39

Beta

0.74

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

7

Growth Score

19

Sentiment Score

99

Actual DrawDown %

25.1

Max Drawdown 5-Year %

-78.3

Target Price

44.6

P/E

Forward P/E

PEG

P/S

P/B

8.17

P/Free Cash Flow

EPS

-2.77

Average EPS Est. Cur. Y​

-2.58

EPS Next Y. (Est.)

-2.38

Target Price Estimates Raised

4

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.97

Return on Equity vs Sector %

-86.4

Return on Equity vs Industry %

-70.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

IMVT Healthcare
$34.15
📉
Swing / Pullback
Buy the dip on strong trends
36 /100
WEAK
Trend
8/20
Pullback
6/25
Volume
4/15
Valuation
8/20
TP/AR
2/10
Options
8/10
RSI
66.7
Range 1M
80.5%
Sup Dist
4.3%
🚀
Momentum Growth
Ride accelerating trends
41 /100
WEAK
Momentum
15/25
Growth
6/30
Estimates
2/20
Inst/Vol
10/15
Options
8/10
EPS Yr
7.7%
EPS NY
2.3%
52W%
90.9%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +30.6% upside
Quality
2/30
Valuation
8/30
Growth
3/25
Stability
7/10
LT Trend
4/5
Upside
+30.6%
Quality
7
Immunovant, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 315
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
IMVT

Latest News

Caricamento notizie per IMVT
stock quote shares IMVT – Immunovant Inc Stock Price stock today
news today IMVT – Immunovant Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch IMVT – Immunovant Inc yahoo finance google finance
stock history IMVT – Immunovant Inc invest stock market
stock prices IMVT premarket after hours
ticker IMVT fair value insiders trading